Financial Incentives, Randomization With Stepped Treatment Trial



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:8/16/2018
Start Date:May 1, 2018
End Date:August 31, 2024
Contact:Elizabeth A Porter, MBA
Email:elizabeth.porter@yale.edu
Phone:+1 (203) 737-3347

Use our guide to learn which trials are right for you!

The investigators plan to determine the effectiveness of contingency management (CM) plus
stepped care for unhealthy alcohol use in HIV-positive patients.

HIV-positive patients with unhealthy alcohol use are not often motivated to decrease their
alcohol consumption and rarely receive treatment for their drinking. To address these
challenges, we plan to provide treatment in HIV clinics, highlight to patients the impact
alcohol can have on their medical conditions, and use Contingency Management (CM) with a
stepped care design to adjust treatment to patient response. CM is an evidence based therapy
that promotes abstinence from substance use, including alcohol. Since CM has not been studied
for unhealthy alcohol use in HIV-infected patients we will include a stepped care strategy
that provides Addiction Psychiatrist Management (APM) (with alcohol pharmacotherapies as
indicated) and Motivational Enhancement Therapy (MET) for patients who do not achieve
abstinence with CM. Phosphatidylethanol (PEth), is a validated biomarker that can confirm
alcohol abstinence over three weeks. To capture the range of adverse effects of alcohol on
health, we will include patients with at-risk drinking, alcohol use disorder, and medical
conditions that can be adversely impacted by alcohol including those with a detectable HIV
viral load, tobacco use disorder, liver fibrosis, untreated hepatitis C, depression and those
taking psychoactive medications that interact with alcohol. The goal of the Financial
Incentives, Randomization with Stepped Treatment (FIRST) Trial is to compare onsite CM plus
stepped care versus treatment as usual (TAU) in a randomized clinical trial of HIV-positive
patients with unhealthy alcohol use at seven HIV clinics. CM patients will receive onsite CM
counseling sessions with financial rewards contingent on abstinence demonstrated by
breathalyzer and PEth. Rewards can also be awarded for addressing medical conditions impacted
by alcohol and achieving alcohol treatment goals. After three months, patients will be
stepped up to APM and MET if PEth results indicate they have not attained abstinence. This
randomized clinical trial will test the hypothesis that CM plus stepped care leads to greater
abstinence, decreased alcohol consumption and improved HIV biomarkers as measured by the VACS
Index.

Inclusion Criteria:

- Be HIV-infected.

- Recent significant alcohol consumption as determined by a PEth greater than 20 ng/ml.

- Able to provide informed consent.

- Meet any of the following criteria for unhealthy alcohol use:

- At-risk Drinking - greater than 14 drinks per week or greater than 4 drinks per
occasion in men and greater than 7 drinks per week or greater than 3 drinks per
occasion in women and those over 65.161

- Medical condition impacted by alcohol as evidenced by one of the following: 1)
detectable HIV viral load (>200 copies/ml),) tobacco use disorder and smoking more
than 5 cigarettes per day, 3) detectable HCV virus, 4) liver fibrosis with a FIB-4
>1.45) Patient Health Questionnaire (PHQ-9, validated measure for depression) score
greater than 9, or 6) current (at least 30 day supply in the past 60 days)
prescription for a psychoactive medication that interacts with alcohol-including
benzodiazepines, opioids, antipsychotics, antidepressants, sleeping medications and
muscle relaxants.

- Alcohol Use Disorder - Meet DSM-5 criteria for alcohol use disorder, not in remission

Exclusion Criteria:

No subject may:

- Be acutely suicidal, or with a psychiatric condition that affects his/her ability to
provide informed consent or participate in counseling interventions (e.g. psychotic,
dementia, delusional).

- Be currently enrolled in formal treatment for alcohol (excluding mutual-help, e.g.
Alcoholics Anonymous)

- Have medical conditions that would preclude completing or be of harm during the course
of the study.

- Be a pregnant or nursing woman or women who do not agree to use a reliable form of
birth control.

- Have a current diagnosis of or be in remission for a gambling disorder given the
gaming nature of CM.
We found this trial at
7
sites
423 East 23rd Street
New York, New York 10010
Phone: 212-951-3417
?
mi
from
New York, NY
Click here to add this to my saved trials
1670 Clairmont Road
Atlanta, Georgia 30033
Phone: 404-321-6111
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bronx, New York 10468
Phone: 718-584-9000
?
mi
from
Bronx, NY
Click here to add this to my saved trials
Dallas, Texas 75216
Phone: 214-857-1410
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Houston, Texas 77030
Phone: 713-794-8856
?
mi
from
Houston, TX
Click here to add this to my saved trials
11301 Wilshire Boulevard
Los Angeles, California 90073
Phone: 310-478-3711
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
50 Irving Street Northwest
Washington, District of Columbia 20422
Phone: 202-745-7560
?
mi
from
Washington,
Click here to add this to my saved trials